Determinants of Non-Adherence to the Medications for Dyslipidemia: A Systematic Review
Open Access
- 1 August 2021
- journal article
- review article
- Published by Taylor & Francis in Patient Preference and Adherence
- Vol. ume 15, 1853-1871
Abstract
Purpose: Dyslipidemia is a major cardiovascular risk factor, and its control leads to less cardiovascular events. Many patients will need some medications to achieve ideal targets. Non-adherence to medications is a complex problem with high impact on their effectiveness. This study aims to identify the determinants of non-adherence to medications in patients with dyslipidemia. Patients and Methods: We conducted a systematic review. PubMed and Scopus databases were searched for original articles, published between 2000 and 2020, using the MeSH terms “Dyslipidemias” and “Medication Adherence”. Results: From the initial 3502 identified articles, we selected 46 to include in the final qualitative synthesis. The determinants associated with non-adherence were lower age (≤ 50 years), female sex, African American ethnicity, smoking habits, being a new user of lipid-lowering medications, reporting or having concerns about lipid-lowering medication side effects and some comorbidities (chronic obstructive pulmonary disease, Alzheimer’s disease/dementia, depression and diabetes). On the contrary, adherence is higher in older patients, alcohol drinking habits, taking β-blockers, having a higher number of comorbidities, having a history of cardiovascular events, cardiac interventions or revascularization procedures, having health insurance and having more provider follow-up visits. Conclusion: There are important identifiable determinants of non-adherence in patients with dyslipidemia. These patients benefit from a specific approach to minimize the problem and maximize the potential benefit of the prescription.Keywords
This publication has 64 references indexed in Scilit:
- Factors associated with compliance to lipid-lowering treatment in ChinaEuropean Journal of Preventive Cardiology, 2012
- Adherence with statins in a real-life setting is better when associated cardiovascular risk factors increase: a cohort studyBMC Cardiovascular Disorders, 2011
- Subjects at Risk of Discontinuation of Lipid-Lowering Agents: A 6-Month Cohort Study Among 12,875 Patients in a Chinese PopulationClinical Therapeutics, 2011
- Predictors of Nonadherence to Statins: A Systematic Review and Meta-AnalysisAnnals of Pharmacotherapy, 2010
- Long-term persistence with statin treatment in a not-for-profit health maintenance organization: A population-based retrospective cohort study in IsraelClinical Therapeutics, 2008
- Impact of prescription size on statin adherence and cholesterol levelsBMC Health Services Research, 2007
- Adherence to MedicationNew England Journal of Medicine, 2005
- Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control studyThe Lancet, 2004
- Discontinuation and switching of therapy after initiation of lipid‐lowering drugs: the effects of comorbidities and patient characteristicsBritish Journal of Clinical Pharmacology, 2003
- Prescription and adherence to statins of patients with coronary artery disease and hypercholesterolemiaArquivos Brasileiros de Cardiologia, 2001